The pharmacokinetics and pharmacodynamics of single dose (R)- and (S)-warfarin administered separately and together: relationship to VKORC1 genotype

Por Maddison, John, Somogyi, Andrew A, Jensen, Berit P, James, Heather M, Gentgall, Melanie, Rolan, Paul E
Publicado em 2013

The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia

Por Davies, Benjamin J, Coller, Janet K, James, Heather M, Somogyi, Andrew A, Horowitz, John D, Sallustio, Benedetta C
Publicado em 2006

Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects

Por Gelston, Eloise A, Coller, Janet K, Lopatko, Olga V, James, Heather M, Schmidt, Helmut, White, Jason M, Somogyi, Andrew A
Publicado em 2012

Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients

Por Coller, Janet K, Michalakas, Jennifer R, James, Heather M, Farquharson, Aaron L, Colvill, Joel, White, Jason M, Somogyi, Andrew A
Publicado em 2012

Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline

Por Davies, Benjamin J L, Coller, Janet K, James, Heather M, Gillis, David, Somogyi, Andrew A, Horowitz, John D, Morris, Raymond G, Sallustio, Benedetta C
Publicado em 2004